Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amgen Receives Positive CHMP Opinion for Vectibix (Panitumumab) in Combination With Chemotherapy
Amgen Receives Positive CHMP Opinion for Vectibix (Panitumumab) in Combination With Chemotherapy
Amgen Receives Positive CHMP Opinion for Vectibix (Panitumumab) in Combination With Chemotherapy
Submitted by
admin
on June 25, 2011 - 10:33am
Source:
Yahoo/PR NewsWire
News Tags:
Amgen
Vectibix
colorectal cancer
Headline:
Amgen Receives Positive CHMP Opinion for Vectibix (Panitumumab) in Combination With Chemotherapy
Do Not Allow Advertisers to Use My Personal information
